Leverage out cutting-edge technology with AI-aided computational chemistry and
biology to design drug lead compounds with better drug-like properties
and binding
affinity to proteins in silico predictions.
Leverage out cutting-edge technology with AI-aided computational chemistry and biology to
design drug lead compounds with better drug-like properties and binding affinity to
proteins in silico predictions.